Notice of extraordinary general meeting of Humana AB
Ambea AB ( publ ) (”Ambea”) controls more than 90 per cent of the total number of shares and votes in Humana AB (”Humana”). Ambea has requested that the Board of Directors convene an Extraordinary General Meeting (the “EGM”) to deal with the matters set out in the proposed agenda.
The shareholders of Humana AB are invited to participate in the EGM to be held on 30 October 2026, at 10:00 at Humana’s headquarter at Warfvinges väg 39, 7 floors, Stockholm, Sweden. Admission and registration to the EGM will begin at 09:30.
RIGHT TO ATTEND AND NOTIFICATION
Participation at the meeting venue
A person who wishes to attend the meeting venue in person or by proxy must
- be entered as a shareholder in the share register kept by Euroclear Nordics AB as of 22 October 2026; and
- give notice of its participation no later than on 26 October 2026 by mail to Humana AB, c/o Euroclear Nordics AB, Box 191, SE-101 23 Stockholm, by phone +46 8-402 91 60, by email to generalmeetingservice@euroclear.com or through the company’s website, https://www.humanagroup.se/english. Upon the notification of participation, the shareholder must state name/business name, personal or corporate identity number, address, telephone number and number of any assistants (not more than two).
For shareholders who wish to be represented by proxy, a written and dated power of attorney signed by the shareholder must be issued for the representative. If the shareholder is a legal entity, a copy of certificate of incorporation, or corresponding authorisation document for the legal entity, must be attached. Form of proxy is available on the company’s website, https://www.humanagroup.se/english. In order to facilitate the registration at the EGM, the power of attorney together with any registration certificate or other authorisation documents should be received by the company at the address set out above in connection with the notice of participation.
NOMINEE REGISTERED SHARES
In order to be entitled to participate in the EGM, a shareholder whose shares are registered in the name of a nominee must, in addition to giving notice of its participation in the EGM, register its shares in its own name so that the shareholder is listed in the presentation of the share register as of 22 October 2026. Such registration may be temporary (so-called voting rights registration), and request for such voting rights registration shall be made to the nominee, in accordance with the nominee’s routines, at such a time in advance as decided by the nominee. Voting rights registrations that have been made by the nominee no later than 26 October 2026 will be taken into account in the presentation of the share register.
PROPOSED AGENDA
1. Opening of the meeting
2. Election of Chairperson of the meeting
3. Preparation and approval of the voting list
4. Approval of the agenda
5. Election of one or two persons to approve the minutes
6. Determination of whether the meeting has been duly convened
7. Determination of the number of Board members
8. Determination of remuneration to the Board members
9. Election of Board members and Chairperson of the Board
10. Closing of the meeting
PROPOSALS
Election of Chairperson of the meeting (item 2)
The Board of Directors has proposed that Anders Nyberg be elected Chairperson of the EGM or, to the extent he is prevented, the person that the Board appoints instead.
Preparation and approval of the voting list (item 3)
The voting list proposed for approval is the voting list drawn up by Euroclear Nordics AB on behalf of the company, based on the EGM’s register of shareholders, shareholders having given notice of participation and being present at the meeting venue, and postal votes received.
Determination of the number of Board members (item 7)
Ambea proposes three (3) ordinary Board members, without deputies.
Resolution on remuneration to the Board members (item 8)
Ambea proposes that no remuneration shall be paid to the Board members.
Election of Board members and Chairperson of the Board (item 9)
Ambea proposes election of Mark Jensen, Benno Eliasson and Johan Regnér as new Board members. Ambea further proposes election of Mark Jensen as new Chairperson of the Board.
Mark Jensen
Mark Jensen, born in 1971, is President and CEO of Ambea and Chairperson of Vårdföretagarna and Svenska Brasserier AB. He previously served as CEO of MTR Nordic Group and, prior to that, held several senior management positions within the Carlsberg Group, including as CEO of Carlsberg Sweden. He has completed internal leadership programmes within Dansk Supermarked and the Carlsberg Group, including “Leading for Results” at London Business School, courses at Aarhus School of Business and reserve officer training at The Army Engineer- and ABC School in Farum, Denmark.
Benno Eliasson
Benno Eliasson, born in 1965, is CFO of Ambea. He previously served as Group CFO of HL Display, CFO of Proffice Group (subsequently Randstad Nordics), Deputy CEO of ATG and CFO of Ikano Bank. He holds a degree in Business Administration and Economics from Linnaeus University.
Johan Regnér
Johan Regnér, born in 1962, is Group Treasurer / Corporate Finance Manager of Ambea. He previously served as acting Global Head of Finance, and Head of Treasury at Enskilda Securities, as well as Financial Risk Controller at Ericsson Radio Systems. He holds a degree in Business Administration and Economics from Örebro University.
DOCUMENTS
The proxy form is available on the company’s website https://www.humanagroup.se/english.
The documents will be sent free of charge to shareholders who so request and state their postal address.
Shareholders’ right to receive information
The Board of Directors and the CEO shall, upon any shareholder’s request and if the Board of Directors believes that it can be done without material harm to the company, provide information at the EGM regarding circumstances that may affect the assessment of an item on the agenda.
Shareholders who wish to submit questions in advance may do so by mail to Humana AB, Att: Investor Relations, Warfvinges väg 39, SE-112 51 Stockholm, or via e-mail to ewelina.pettersson@humana.se.
NUMBER OF SHARES AND VOTING RIGHTS
The total number of shares and votes in the company amounts to 48,039,394. As per the date of this notice, the company holds 518,261 treasury shares.
PROCESSING OF PERSONAL DATA
For information on how your personal data is processed, please refer to https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.
If you have any questions regarding our processing of your personal data, you can contact us via email at dataskyddsombud@humana.se. Humana AB has corporate registration number 556760-8475 and the Board of Directors’ registered office is in Stockholm.
____________
Stockholm, October 2026
Humana AB (publ)
The Board of Directors
About Us
Humana is a leading Nordic care company providing services within individual and family care, personal assistance, elderly care and special service housing in accordance with LSS. Humana has 22,000 employees in Sweden, Norway and Finland providing care for approximately 8,000 individuals and working to achieve the vision “Everyone is entitled to a good life”. In 2025, Humana’s net revenue was SEK 10,011m. Humana is listed on Nasdaq Stockholm and the company’s headquarters are located in Stockholm. Read more about Humana on: https://www.humanagroup.com/